DaVita
$117.859876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$117.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.41 (-1.18%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours
Why Robinhood?
You can buy or sell DaVita and other stocks, options, and ETFs commission-free!
About DVA
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO. The listed name for DVA is DaVita Inc.
CEO
Javier J. Rodriguez
Employees
65,000
Headquarters
Denver, Colorado
Founded
1994
Market Cap
13.12B
Price-Earnings Ratio
18.09
Dividend Yield
—
Average Volume
594.43K
High Today
$118.92
Low Today
$116.92
Open Price
$118.32
Volume
615.47K
52 Week High
$125.28
52 Week Low
$62.20
Collections
Analyst Ratings
23%
of 13 ratings
Buy
23%
Hold
69%
Sell
8%
DVA Earnings
$0.00
$0.65
$1.30
$1.95
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 10, After Hours